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Fine-needle aspiration cytology of soft tissue sarcoma: bene® ts and
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Abstract
Purpose. Examine the bene® ts and limitations of ® ne-needle aspiration cytology (FNA) used as the de® nitive diagnostic
method before treatment.
Method. Review of the 25 year experience at a multidisciplinary musculo-skeletal centre where FNA is the primary
diagnostic approach to soft tissue sarcoma in the extremities and trunk wall and the experience of various experts in the
® eld.
Results. FNA has several bene® ts compared with coarse needle or open surgical biopsy. The most important are rapid
preliminary diagnosis, no need for hospitalization and anaesthesia, negligible complications and fear for tumour cell
spread. With the collected experience gained during the years a reliable diagnosis of sarcoma is the rule in general and
speci® c-type diagnoses are possible in many histotypes, especially when the cytologic examination is supplemented with
ancillary diagnostics. The most important limitations are inability to hit small deep-seated sarcoma and some diagnostic
pitfalls such as the correct diagnosis of spindle cell neoplasms, variants of benign lipomatous tumours and `new soft tissue
tumour entities’.
Discussion. Optimal use of FNA calls for certain requirements such as centralization, experience in soft tissue tumour
cytology± histopathology, the FNA technique and close co-operation between the orthopaedic surgeon and cytopathologist.
Key words: ® ne needle aspiration, diagnosis, soft tissue sarcoma, bene® ts, limitations.
Introduction
Open surgical biopsy or coarse needle biopsy are
widely considered to be the diagnostic procedures
necessary before the de® nitive treatment of a soft
tissue sarcoma. Fine-needle aspiration and cytodiag-
nosis (FNA) has not been universally accepted as a
pretreatment diagnostic method although numerous
reports on the use of FNA in the diagnosis of soft
tissue tumours have been published during the last
20 years.
1± 6 The subsequent review on the bene® ts
and limitations of FNA as the de® nitive diagnostic
method of soft tissue sarcoma before treatment is
based on a 25 year experience of FNA of soft tissue
tumours in the extremities and trunk wall from the
multidisciplinary Musculo-Skeletal Tumour Centre
at the University Hospital, Lund as well as on cited
references.
Bene® ts of FNA
FNA offers several advantages compared with open
as well as coarse needle biopsy. FNA of soft tissue
tumours is a harmless out-patient procedure. Severe
complications are non-existent; at most there is a
tenderness for some days after the needling and a
local haemorrhage. Anaesthesia and hospitalization
are not necessary. In children, a short general anaes-
thesia may be needed, depending on the clinical
presentation of the tumour. When the aspirations
are performed by cytopathologists it is easy to per-
form a rapid staining of the ® rst smear and within
10± 15 minutes ensure that the material is suf® cient
and diagnosable and to suggest a preliminary diag-
nosis. Further investigations and/or suggested treat-
ment can then be discussed with the patient at the
® rst visit, which is important when patients are
referred from other hospitals. Properly performed
FNA is the least tissue-invasive diagnostic pro-
cedure and the risk for sarcoma-cell spread is negli-
gible.
Compared with coarse needle biopsy, which is
also an out-patient procedure, a rapid preliminary
report is easier to render as well as the sampling of
tumour material from different parts of large tu-
mours in order to diagnose tumour heterogeneity,
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Fig. 1. Part of the smears from aspirates from two different areas of a large intramuscular sarcoma. Left: typical myxoid liposarcoma
with myxoid background, branching capillaries and scattered lipoblasts. Right: Cellular tumour fragment with closely packed lipoblasts
corresponding to round cell liposarcoma. (MMG 3 250).
which can provide important diagnostic information
(Fig. 1). The economical bene® ts are not only due
to reduced costs for hospitalization and the use of an
operating room, but the number of patient visits is
also reduced.
The most important objections against the use of
FNA as the de® nitive diagnosis of soft tissue
tumours in general is the proposed inability for the
cytopathologist to give a reliable histotype diagnosis
and malignancy grade.
7,8 The bene® ts and limita-
tions of FNA in the de® nitive diagnosis of a soft
tissue sarcoma must, however, be related to the
proposed treatment. When primary surgery is con-
sidered, the surgeon must have a reliable diagnosis
of sarcoma. The type of surgery performed depends
more on the site and size of the sarcoma and its
relation to vessels, nerve bundles and periosteum
than on the histogenetic type. Thus with this treat-
ment modality the cytopathologist must be able to
exclude other malignancies as soft tissue metastases
and primary soft tissue malignant lymphoma and to
differentiate between benign soft tissue tumours/
lesions and sarcoma. On the other hand, when the
treatment option is neoadjuvant therapy followed by
surgery, the FNA diagnosis must equal that of a
biopsy or coarse needle specimen with regard to
speci® c sarcoma type and malignancy grade.
Primary surgery of soft tissue sarcoma
At present the ® ne-needle aspiration cytology of
numerous benign soft tissue tumours/lesions as well
as soft tissue sarcoma histotypes have been investi-
gated and diagnostic criteria suggested (Table 1).
One important group of lesions in which the
bene® ts of FNA are well documented is in the
diagnosis of the various pseudosarcomatous soft tis-
sue lesions (nodular fasciitis, proliferative fasciitis
and myositis and pseudomalignant myositis
ossi® cans). The clinical presentation of these lesions
is often suspicious for malignancy; rapid growth,
® rm at palpation and ® xed to underlying structures
and biopsy specimens or excised lesions have been
misinterpreted as sarcoma. The FNA cytology of
these lesions has been thoroughly studied.
9± 12 It has
also been documented that the need for surgical
intervention most often is unnecessary as the
Table 1. Soft tissue sarcomas cytolo-
gically characterized in FNA smears
by correlative cytological± histological
studies
Malignant ® brous histiocytoma
Myxo® brosarcoma
Liposarcoma
Leiomyosarcoma
Synovial sarcoma
Clear cell sarcoma
Alveolar soft part sarcoma
Rhabdomyosarcoma
Ewing’s sarcomaBene® ts and limitations of FNA cytology 157
Fig. 2. Low-power view of a low-grade myxo® brosarcoma. Left: aspirate; right: part of the surgical specimen. The typical
histopathological features are easily observed in the smear: myxoid background matrix, curvo-linear vessels and slight atypia. (MMG
and HE 3 250).
Fig. 3. Highly atypical lipoblasts in an aspirate from a pleomorphic liposarcoma. (MGG 3 1000).
also been documented that the need for surgical
intervention most often is unnecessary as the
majority of these tumour-like lesions disappear com-
pletely or greatly diminish in size some weeks after
the needling.
11,13,14
The cytologic appearance in FNA smears of the
most common sarcomasÐ pleomorphic sarcoma of
the MFH-type, myxo® brosarcoma (Fig. 2), myxoid,
round cell and pleomorphic liposarcoma (Fig. 3),
leiomyosarcoma (Fig. 4) and synovial sarcomaÐ has
been described in various series of correlative cyto-
logic± histologic studies.
15± 22 Less frequent sarcomas
such as clear cell sarcoma, alveolar soft part sar-
coma, rhabdomyosarcoma and (extraskeletal)
Ewing’s sarcoma/PNET (peripheral neuroectoder-
mal tumour) have also been characterized in FNA
material.
23± 28
There is a number of sarcoma entities which are
insuf® ciently characterized in FNA, among them
especially malignant vascular tumours. It is often
possible, however, to give a con® dent sarcoma diag-
nosis in these cases, the evaluation of malignancy
based on the smear pattern, the uniform or
pleomorphic cytologically malignant cell population,158 M. A Ê kerman
Fig. 4. In pleomorphic, high-grade malignant leiomyosarcoma the typical blunt-ended cigar-shaped nuclei may be found.
(MGG 3 1000).
numerous mitotic ® gures and fragments of necrotic
tumour tissue.
Neoadjuvant therapy followed by surgery
At present, neoadjuvant therapy is considered in the
small round cell sarcomas such as rhabdomyosar-
coma, extraskeletal Ewing’s sarcoma, PNET, and
synovial sarcoma and in selected large, deep-seated
high-grade malignant soft tissue sarcoma of various
histotypes.
When neoadjuvant therapy (radiotherapy or
chemotherapy) is part of the de® nitive treatment,
the cytodiagnosis must include a con® dent histo-
type diagnosis and in cases of preoperative radio-
therapy of deep-seated sarcoma also a reliable
malignancy grading. Cytologic malignancy grading
of soft tissue sarcoma into low or high grade is
possible and is based on the evaluation of cellular
and nuclear pleomorphism and atypia, mitotic
activity, especially the presence of atypical mitoses,
and necrosis. The histogenetic type of a sarcoma
might also be important in the decision of malig-
nancy grade, for example, pure myxoid liposarcoma
is most often a low-grade tumour while synovial
sarcoma is high-grade. According to our experience
a reliable malignancy grading into low or high grade
malignant sarcoma is possible to perform in about
75% of sarcomas needled.
29
The cytologic features of rhabdomyosarcoma,
Ewing’s sarcoma, PNET, and synovial sarcoma in
FNA smears have been studied and diagnostic cri-
teria de® ned. Although these criteria may be the
basis of a con® dent type-diagnosis the cytologic
examination should be supplemented with various
ancillary diagnostic methods. In FNA aspirates it is
possible to make use of the same supplementary
techniques as in surgical specimens and the use of
adjunctive diagnostic methods in FNA is well docu-
mented.
25,30± 34
At present routine cytologic examination com-
bined with ancillary diagnostics successfully and
reliably can diagnose most small round cell sarco-
mas and synovial sarcomas before the neoadjuvant
therapy. In many pleomorphic high-grade sarcomas
it is also possible to de® ne the histotype.
Limitations of FNA
The limitations of FNA in the diagnosis of soft
tissue sarcoma are threefold: (a) the sarcoma is not
hit with the needle and a false diagnosis may be
rendered on the reactive cellular changes in the
aspirated surrounding tissues; (b) insuf® cient
material (poor yield or technically inferior smears)
from the tumour is evaluated; and (c) misinterpret-
ation of the aspirated cells. According to our 25 year
experience one important reason for a false diag-
nosis is that the material examined does not orig-
inate from the sarcoma but from the surrounding
tissues. In these cases either a benign diagnosis is
given or a false sarcoma-type diagnosis is suggested,
based on reactive, pseudomalignant cellular
changes, especially reactive changes in adipose tis-
sue resembling liposarcoma or reactive pleomorphic
® broblasts and myo® broblasts falsely interpreted as
originating from a malignant ® brous histiocytoma.
This is most often the case with small deep-seated,
inter- or intramuscular sarcomas.
The main reason for a false diagnosis is, however,
misinterpretation of the cellular material. There is a
number of well-documented diagnostic dif® culties.
One of the most common is the correct evaluation
of tumours predominantly composed of spindle
cells
2,35,36 (Figs 5 and 6). Another important pitfall
is false malignant diagnosis of benign lipoma vari-
ants as pleomorphic and spindle cell lipoma, hiber-
noma and lipoblastoma.
17 A rare diagnostic
dif® culty is the misinterpretation of aspirates from
soft tissue metastases from pleomorphic carcinomaBene® ts and limitations of FNA cytology 159
Fig. 5. A poor yield from two different spindle cell neoplasms. Left: monophasic synovial sarcoma. Right: desmoid ® bromatosis. Similar
cellular shape and nuclear structure. A correct diagnosis is not possible.
or melanoma or primary large cell anaplastic
lymphoma as pleomorphic sarcoma and metastases
from renal clear cell carcinoma as pure round cell
liposarcoma.
Yet another limitation to render a correct diag-
nosis of a soft tissue sarcoma are `new entities’, of
benign or borderline soft tissue tumours. These new
entities are often rare tumours and experience of
histological± cytological correlative studies of reason-
ably large materials are dif® cult to reach. Examples
of new entities which may be falsely diagnosed as
sarcoma are chondroid lipoma, perineurioma and
solitary ® brous tumour.
Discussion
The clinical bene® ts of FNA in the primary,
de® nitive diagnosis of soft tissue sarcoma are advan-
tageous, but to reach a reasonably high diagnostic
accuracy certain requirements should be observed.
A close co-operation between the surgeon and cyto-
pathologist is mandatory. The surgeon often will
decide the insertion point of the needle and when
demanding a preliminary report, discuss the diag-
nosis with the cytopathologist in relation to the
clinical history, palpatory ® ndings and radiographic
investigations, if any. The ® nal diagnosis should be
the combined evaluation of clinical and radiographic
data and the cytodiagnosis. In order to avoid false
diagnoses due to a faulty aspiration technique and
inability to hit the tumour at needling the cyto-
pathologist must be a trained aspirator with a fair
knowledge of the clinical behaviour and histopathol-
ogy of soft tissue tumours. Ultrasound-guided aspi-
rations of small deep-seated sarcoma are
recommended to ensure that the needle is within the
tumour.
As soft tissue sarcomas are relatively rare tumours
(in Sweden the annual incidence is 2± 3/10
6 inhabi-
tants) and many benign soft tissue tumours clini-
cally are suspected to be sarcomas, the optimal use
of FNA is reached when patients with suspected
sarcoma are referred with virgin tumours to multi-
disciplinary musculo-skeletal centres. Benign soft
tissue tumours/lesions are far more common than
soft tissue sarcomas, in order to ensure that the
FNA of the majority of sarcomas are performed at
Fig. 6. Part of an aspirate from an ancient neurilemoma. A
low-grade malignant spindle cell sarcoma (leiomyosarcoma or
malignant peripheral nerve sheet tumour) may display similar
cellular features. (MGG 3 1000).160 M. A Ê kerman
Table 2. Recommended guidelines for referral of patients with soft tissue
tumours to multidisciplinary musculo-skeletal centres
1. Subcutaneous tumours. 5 cm
2. All deep-seated (inter- or intramuscular) tumours
3. Soft tissue tumours, clinically suspected for malignancy
4. All soft tissue tumours in children
multidisciplinary centres, but where most patients
with benign tumours (especially lipomas) and
benign reactive tumour-like lesions are not referred
we have recommended some guidelines which are
based on epidemiological data
37,38 (Table 2).
One challenge for the cytopathologist is the type-
diagnosis of high-grade deep-seated sarcoma that
are candidates for preoperative radiotherapy. When
the therapy is successful it might be dif® cult to
diagnose reliably the histogenetic type on the surgi-
cal sample. Immunocytochemistry may be helpful in
suggesting smooth muscle or Schwann cell differen-
tiation, but desmin positivity may be patchy in
pleomorphic leiomyosarcoma and many malignant
peripheral nerve sheet tumours do not react with the
anti S-100 protein antibody. Immunocytochemistry
is, however, of help in the differential diagnosis of
soft tissue carcinoma metastases and soft tissue
anaplastic large cell lymphoma versus pleomorphic
sarcoma. Electron microscopic examination of aspi-
rated material is a valuable diagnostic adjunct in
pleomorphic leiomyosarcoma and to certify a diag-
nosis of round cell or pleomorphic liposarcoma. The
diagnosis of monophasic synovial sarcoma is a well-
known problem in FNA cytodiagnosis, but we have
had the decisive help of electron microscopic studies
in a number of cases.
22
DNA-ploidy analysis is a limited but valuable
adjunct. An unequivocal non-diploid cell population
is compatible with malignancy and according to our
experience high-grade sarcoma.
31 The small round
cell sarcomas are safely diagnosed by the combined
evaluation of the cytologic features and ancillary
diagnostics. With the aid of immunocytochemical
staining and ultrastructural investigations rhab-
domyosarcoma, extraskeletal Ewing’s sarcoma and
PNET are con® dently diagnosed. Desmin, CD99
(MIC
2-antigen), neuron-speci® c enolase and chro-
mogranin are valuable antibodies in the type-diag-
nosis of these tumours. Cytogenetic and molecular
genetic analyses have emerged as powerful diagnos-
tic tools in those sarcoma where diagnostic translo-
cations have been described and the genes involved
identi® ed. The use of cytogenetics in the diagnosis is
documented in Ewing’s sarcoma and synovial sar-
coma
32,33 and it should be possible to make use of
the known molecular genetic aberrations in the diag-
nosis of liposarcomas with a component of myxoid
liposarcoma and alveolar rhabdomyosarcoma. We
have recently used RT-PCR for the diagnosis of the
PCR for the diagnosis of the SSX1/SYT fusion
genes in a case of suspected synovial sarcoma.
The bene® ts of FNA in the de® nitive diagnosis of
soft tissue sarcoma outweigh the limitations when
(i) there is a close co-operation between cytopathol-
ogist and surgeon (referral of patients to multidisci-
plinary centres), (ii) the diagnosis is based on
reliable and reproducible criteria, (iii) ancillary
methods are part of the diagnosis and (iv) the diag-
nostic pitfalls are identi® ed.
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